Suppr超能文献

腔内近距离放射治疗在胆管癌胆道梗阻姑息治疗中的作用:简要综述。

Role of intraluminal brachytherapy in palliation of biliary obstruction in cholangiocarcinoma: A brief review.

作者信息

Khosla Divya, Zaheer Samreen, Gupta Rahul, Madan Renu, Goyal Shikha, Kumar Narendra, Kapoor Rakesh

机构信息

Department of Radiotherapy and Oncology, Postgraduate Institute of Medical Education and Research, Chandigarh 160012, U.T., India.

Department of Gastroenterology and Hepatology, Shalby Multispeciality Hospital, Mohali 160062, Punjab, India.

出版信息

World J Gastrointest Endosc. 2022 Mar 16;14(3):106-112. doi: 10.4253/wjge.v14.i3.106.

Abstract

Surgery is the only curative treatment for cholangiocarcinoma. However, most patients present with advanced disease, and hence are unresectable. Thus, the intent of treatment shifts from curative to palliative in the majority of cases. Biliary drainage with intraluminal brachytherapy is an effective means of relieving the malignant biliary obstruction. In this review, we discuss the role of brachytherapy in the palliation of obstructive symptoms in extrahepatic cholangiocarcinoma.

摘要

手术是胆管癌唯一的治愈性治疗方法。然而,大多数患者就诊时已处于疾病晚期,因此无法进行手术切除。所以,在大多数情况下,治疗目的从治愈性转变为姑息性。腔内近距离放射治疗联合胆道引流是缓解恶性胆道梗阻的有效方法。在本综述中,我们讨论了近距离放射治疗在缓解肝外胆管癌梗阻症状方面的作用。

相似文献

1
Role of intraluminal brachytherapy in palliation of biliary obstruction in cholangiocarcinoma: A brief review.
World J Gastrointest Endosc. 2022 Mar 16;14(3):106-112. doi: 10.4253/wjge.v14.i3.106.
2
Role of intraluminal brachytherapy as a palliative treatment modality in unresectable cholangiocarcinomas.
J Cancer Res Ther. 2021 Jan-Mar;17(1):10-12. doi: 10.4103/jcrt.JCRT_836_19.
3
Endoscopic intraluminal brachytherapy and metal stent in malignant hilar biliary obstruction: a pilot study.
Liver Int. 2007 Apr;27(3):347-52. doi: 10.1111/j.1478-3231.2006.01439.x.
4
Clinical benefit of radiation therapy and metallic stenting for unresectable hilar cholangiocarcinoma.
World J Gastroenterol. 2012 May 21;18(19):2364-70. doi: 10.3748/wjg.v18.i19.2364.
7
Endoscopic palliation of cholangiocarcinoma.
Curr Opin Gastroenterol. 2006 Sep;22(5):551-60. doi: 10.1097/01.mog.0000239872.12081.a4.
8
Chemoradiation and brachytherapy in extrahepatic bile duct carcinoma.
Crit Rev Oncol Hematol. 2014 Apr;90(1):58-67. doi: 10.1016/j.critrevonc.2013.10.007. Epub 2013 Nov 2.
9
Intraluminal brachytherapy in bile duct carcinomas.
Aust N Z J Surg. 1996 Feb;66(2):74-7. doi: 10.1111/j.1445-2197.1996.tb01115.x.

引用本文的文献

1
The Recent Trends of Systemic Treatments and Locoregional Therapies for Cholangiocarcinoma.
Pharmaceuticals (Basel). 2024 Jul 8;17(7):910. doi: 10.3390/ph17070910.

本文引用的文献

2
BILCAP trial and adjuvant capecitabine in resectable biliary tract cancer: reflections on a standard of care.
Expert Rev Gastroenterol Hepatol. 2021 May;15(5):483-485. doi: 10.1080/17474124.2021.1864325. Epub 2020 Dec 18.
3
Recent advances of immunotherapy for biliary tract cancer.
Expert Rev Gastroenterol Hepatol. 2021 May;15(5):527-536. doi: 10.1080/17474124.2021.1853527. Epub 2021 Jan 8.
4
Circulating Tumor DNA in Biliary Tract Cancer: Current Evidence and Future Perspectives.
Cancer Genomics Proteomics. 2020 Sep-Oct;17(5):441-452. doi: 10.21873/cgp.20203.
5
Systemic treatment options for advanced biliary tract carcinoma.
J Gastroenterol. 2020 Oct;55(10):944-957. doi: 10.1007/s00535-020-01712-9. Epub 2020 Aug 3.
6
Cholangiocarcinoma 2020: the next horizon in mechanisms and management.
Nat Rev Gastroenterol Hepatol. 2020 Sep;17(9):557-588. doi: 10.1038/s41575-020-0310-z. Epub 2020 Jun 30.
8
Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study.
Lancet Oncol. 2020 May;21(5):671-684. doi: 10.1016/S1470-2045(20)30109-1. Epub 2020 Mar 20.
10
Technique for the administration of high-dose-rate brachytherapy to the bile duct using a nasobiliary catheter.
Brachytherapy. 2018 Jul-Aug;17(4):718-725. doi: 10.1016/j.brachy.2018.03.006.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验